Clinical Course of Children with Chronic Suppurative Lung Disease or Bronchiectasis Infected with Pseudomonas aeruginosa

被引:3
作者
Kartsiouni, Elpiniki [1 ]
Chatzipanagiotou, Stylianos [2 ]
Galani, Angeliki [1 ]
Moriki, Dafni [1 ]
Sardeli, Olympia [1 ]
Prountzos, Spyridon [3 ]
Alexopoulou, Efthymia [3 ]
Loukou, Ioanna [4 ]
Priftis, Kostas N. [1 ]
Douros, Konstantinos [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sch Med, Dept Pediat 3,Pediat Allergy & Resp Unit, Athens 12462, Greece
[2] Natl & Kapodistrian Univ Athens, Eginit Hosp, Sch Med, Dept Med Biopathol, Athens 11528, Greece
[3] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Radiol Dept 2, Athens 12462, Greece
[4] Agia Sofia Childrens Hosp, Cyst Fibrosis Dept, Athens 11527, Greece
来源
CHILDREN-BASEL | 2022年 / 9卷 / 12期
关键词
Pseudomonas aeruginosa; bronchiectasis; chronic suppurative lung disease; children; RESOLUTION CT-SCAN; CYSTIC-FIBROSIS;
D O I
10.3390/children9121822
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Children with chronic wet cough and without cystic fibrosis (non-CF) may suffer from chronic suppurative lung disease (CSLD) or bronchiectasis. Pseudomonas aeruginosa (Pa) can be one of the offending microbes in these children. The present study aimed to describe the clinical course of children with the above two conditions who were infected with Pa. Data of 54 children with CSLD/bronchiectasis who were diagnosed and attended in our department were retrospectively analysed through a Cox proportional hazard model, with age, presence of bronchiectasis, use of inhaled colistin, azithromycin, inhaled hypertonic saline as the covariates. In 42 of the 54 patients, there was no identifiable cause or underlying chronic disorder. Microbiological clearance was defined as the absence of daily wet cough for four months along with four negative cultures taken during the last four consecutive follow-up visits. Multivariate analysis was performed with a Cox proportional hazard model with time to microbiological clearance as the outcome. Results are described as Hazard Ratios (HR) with 95% Confidence Intervals (95%CI). Nebulised antibiotics and the presence of bronchiectasis were statistically significant predictors of remission (HR: 3.99; 95%CI: 1.12-14.14; p = 0.032, and HR: 0.24; 95%CI: 0.08-0.71; p = 0.010). In conclusion, the rate of microbiological clearance increases with the use of inhaled colistin and decreases when there is established bronchiectasis.
引用
收藏
页数:7
相关论文
共 26 条
  • [1] CYSTIC-FIBROSIS - SCORING SYSTEM WITH THIN-SECTION CT
    BHALLA, M
    TURCIOS, N
    APONTE, V
    JENKINS, M
    LEITMAN, BS
    MCCAULEY, DI
    NAIDICH, DP
    [J]. RADIOLOGY, 1991, 179 (03) : 783 - 788
  • [2] Microbiological Progress in Patients with Bronchial Infection with <it><bold>Pseudomonas aeruginosa</it></bold> Treated with Nebulised Colistin
    Bruguera-Avila, Nuria
    Garcia-Olive, Ignasi
    Marin, Alicia
    Prat, Cristina
    Lacoma, Alicia
    Gil, Montserrat
    Abad Capa, Jorge
    [J]. RESPIRATION, 2019, 97 (06) : 501 - 507
  • [3] European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
    Chang, Anne B.
    Fortescue, Rebecca
    Grimwood, Keith
    Alexopoulou, Efthymia
    Bell, Leanne
    Boyd, Jeanette
    Bush, Andrew
    Chalmers, James D.
    Hill, Adam T.
    Karadag, Bulent
    Midulla, Fabio
    McCallum, Gabrielle B.
    Powell, Zena
    Snijders, Deborah
    Song, Woo-Jung
    Tonia, Thomy
    Wilson, Christine
    Zacharasiewicz, Angela
    Kantar, Ahmad
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (02)
  • [4] Bronchiectasis in children: diagnosis and treatment
    Chang, Anne B.
    Bush, Andrew
    Grimwood, Keith
    [J]. LANCET, 2018, 392 (10150) : 866 - 879
  • [5] Protracted bacterial bronchitis: The last decade and the road ahead
    Chang, Anne B.
    Upham, John W.
    Masters, I. Brent
    Redding, Gregory R.
    Gibson, Peter G.
    Marchant, Julie M.
    Grimwood, Keith
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 (03) : 225 - 242
  • [6] COLE PJ, 1986, EUR J RESPIR DIS, V69, P6
  • [7] The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
    Davies, G.
    Wells, A. U.
    Doffman, S.
    Watanabe, S.
    Wilson, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) : 974 - 979
  • [8] Asthma-Like Features and Anti-Asthmatic Drug Prescription in Children with Non-CF Bronchiectasis
    Douros, Konstantinos
    Sardeli, Olympia
    Prountzos, Spyridon
    Galani, Angeliki
    Moriki, Dafni
    Alexopoulou, Efthymia
    Priftis, Kostas N.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 6
  • [9] Bronchoscopic and High-Resolution CT Scan Findings in Children With Chronic Wet Cough
    Douros, Konstantinos
    Alexopoulou, Efthymia
    Nicopoulou, Aggeliki
    Anthracopoulos, Michael B.
    Fretzayas, Andrew
    Yiallouros, Panayiotis
    Nicolaidou, Polixeni
    Priftis, Kostas N.
    [J]. CHEST, 2011, 140 (02) : 317 - 323
  • [10] Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships
    Edwards, EA
    Metcalfe, R
    Milne, DG
    Thompson, J
    Byrnes, CA
    [J]. PEDIATRIC PULMONOLOGY, 2003, 36 (02) : 87 - 93